查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942837

2026年全球外泌体诊断与治疗市场报告

Exosome Diagnostic And Therapeutic Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，外泌体诊断和治疗市场发展迅速。预计该市场将从2025年的6亿美元成长到2026年的7.7亿美元，复合年增长率（CAGR）为28.0%。这一增长被认为归功于分子生物学研究的进步、再生医学投资的增加、细胞外囊泡学术研究的拓展、生物技术研究基础设施的扩充以及外泌体分析工具的日益普及。

预计未来几年，外泌体诊断和治疗市场将呈指数级增长，到2030年市场规模将达到20.7亿美元，复合年增长率（CAGR）为28.0%。预测期内的成长要素包括外泌体疗法临床应用的拓展、对个人化医疗解决方案需求的不断增长、基于人工智慧的外泌体数据分析的扩展、製药业对生物製药递送系统日益增长的兴趣，以及先进治疗方法监管政策的逐步明朗。预测期内的主要趋势包括外泌体在标靶药物递送领域的应用日益广泛、液态生物检体诊断技术的普及、再生医学应用需求的增长、先进外泌体分离技术的扩展，以及对精准医疗发展的日益重视。

外泌体诊断和治疗市场的预期成长主要受慢性病盛行率上升的推动。持续超过三个月且病情往往随时间恶化的慢性病是全球重要的健康议题。外泌体可用于诊断和治疗，正逐渐成为癌症领域极具潜力的生物标记物，能够实现更灵敏的疾病监测，并促进个人化医疗的普及。根据美国国家生物技术资讯中心 (NCBI) 2023 年 1 月的预测，到 2050 年，全球慢性疾病患者人数预计将达到 1.4266 亿。这项数据凸显了慢性病盛行率上升将在推动外泌体诊断和治疗市场发展方面发挥的关键作用。

主要企业正积极研发创新产品，例如样品纯化系统，以拓展基本客群、提升销售额并推动营收成长。样品纯化系统是指一系列旨在去除各种样品类型（包括DNA、RNA、蛋白质和其他生物分子）中的杂质和污染物的製程和技术。例如，2023年2月，美国领先的生物技术公司Biological Dynamics Inc.推出了ExoVerita，这是一个专为早期疾病监测和各种应用而设计的外泌体分离平台。作为该平台的一部分，ExoVita胰腺检测已证实能够识别特定的外泌体蛋白标记物，并利用经取得专利的ExoVerita装置富集的血液来源外泌体样本检测I期和II期胰腺导管腺癌（PDAC）。该公司目前正在进行 ExoLuminate 註册试验 (NCT05625529)，该试验将评估该检验在高风险 PDAC 患者中的临床价值，并正在积极验证这些发现。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球外泌体诊断和治疗市场：吸引力评分和分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧与自主智能
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 外泌体在标靶药物传递的应用日益广泛
    • 液态生物检体诊断技术的日益普及
    • 对再生医学应用的需求不断增长
    • 扩展先进的外泌体分离技术
    • 人们越来越关注精准医疗的发展

第五章 终端用户产业市场分析

  • 学术研究机构
  • 製药公司
  • 生技公司
  • 医院和诊所
  • CRO（受託研究机构）

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球外泌体诊断和治疗市场：PESTEL 分析（政治、社会、技术、环境、法律、驱动因素和限制因素）
  • 全球外泌体诊断与治疗市场规模、对比及成长率分析
  • 全球外泌体诊断与治疗市场表现：规模与成长，2020-2025年
  • 全球外泌体诊断与治疗市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 设备、软体、试剂和试剂盒
  • 透过使用
  • 诊断和治疗
  • 最终用户
  • 学术研究机构、製药和生物技术公司、医院和诊所以及其他最终用户
  • 按类型细分：设备
  • 外泌体分离系统、表征装置、分析仪器
  • 按类型细分：软体
  • 数据分析软体，外泌体分析软体
  • 按类型细分：试剂和试剂盒
  • 分离试剂盒、鑑定试剂、检测试剂盒

第十章 区域与国家分析

  • 全球外泌体诊断与治疗市场：按地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球外泌体诊断与治疗市场：依国家/地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 外泌体诊断与治疗市场：竞争格局与市场份额，2024 年
  • 外泌体诊断与治疗市场：公司估值矩阵
  • 外泌体诊断与治疗市场：公司概况
    • Thermo Fisher Scientific Inc.
    • Miltenyi Biotec GmbH
    • Malvern Instruments Inc.
    • System Biosciences LLC
    • NanoSomix Inc.

第37章：其他领先和创新企业

  • Exosome Diagnostics Inc., Evox Therapeutics Ltd., ExCoBio Inc., Codiak BioSciences Inc., Capricor Therapeutics Inc., Aethlon Medical Inc., NX Pharmagen Inc., Aegle Therapeutic Corporation, Ciloa, Sistemic Inc., Theoria Science, Mantra Bio Inc., Lonza Group AG, Bio-Techne Corp.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年外泌体诊断与治疗市场：提供新机会的国家
  • 2030年外泌体诊断与治疗市场：提供新机会的细分领域
  • 2030年外泌体诊断与治疗市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MEDTI02_G26Q1

Exosome diagnostics and therapeutics involve utilizing exosomes-small extracellular particles produced by cells-for both diagnostic and therapeutic purposes. Exosomes are employed in therapeutic applications as a means of delivering targeted medications, particularly within the field of regenerative medicine.

The primary products within the exosome diagnostic and therapeutic market comprise instruments, software, reagents, and kits. Instruments refer to equipment utilized for precise and accurate execution of activities or experiments. These products find diverse applications in diagnostics and therapeutics and cater to various end-users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, among others.

Tariffs are influencing the exosome diagnostic and therapeutic market by increasing costs of imported analytical instruments, isolation systems, reagents, consumables, and laboratory automation equipment. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on specialized imported tools, while Asia-Pacific faces cost pressures on manufacturing and export of research-grade systems. These tariffs are increasing research and development expenditure and slowing procurement timelines. However, they are also supporting local manufacturing of laboratory equipment, regional reagent production, and domestic innovation ecosystems for advanced biologics research.

The exosome diagnostic and therapeutic market research report is one of a series of new reports from The Business Research Company that provides exosome diagnostic and therapeutic market statistics, including exosome diagnostic and therapeutic industry global market size, regional shares, competitors with a exosome diagnostic and therapeutic market share, detailed exosome diagnostic and therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the exosome diagnostic and therapeutic industry. This exosome diagnostic and therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.6 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 28.0%. The growth in the historic period can be attributed to advancements in molecular biology research, rising investment in regenerative medicine, increasing academic research on extracellular vesicles, expansion of biotech research infrastructure, growing availability of exosome analysis tools.

The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $2.07 billion in 2030 at a compound annual growth rate (CAGR) of 28.0%. The growth in the forecast period can be attributed to increasing clinical translation of exosome therapies, rising demand for personalized medicine solutions, expansion of ai-enabled exosome data analysis, growing pharmaceutical interest in biologic delivery systems, increasing regulatory clarity for advanced therapies. Major trends in the forecast period include increasing use of exosomes for targeted drug delivery, rising adoption of liquid biopsy diagnostics, growing demand for regenerative medicine applications, expansion of advanced exosome isolation technologies, enhanced focus on precision therapeutic development.

The anticipated growth of the exosome diagnostic and therapeutic market is strongly driven by the increasing prevalence of chronic diseases. Chronic illnesses, lasting three months or more and prone to deterioration over time, are a significant health concern globally. Exosomes, utilized in both diagnostic and therapeutic capacities, emerge as promising biomarkers in cancer, enabling more sensitive disease monitoring and facilitating the accessibility of personalized medicine. In a projection from January 2023, the National Center for Biotechnology Information (NCBI) indicates a forecasted global count of 142.66 million individuals with chronic diseases by 2050. This statistic underscores the pivotal role played by the rising prevalence of chronic diseases in propelling the exosome diagnostics and therapeutics market.

Major companies are actively engaged in developing innovative products, such as sample purification systems, to expand their customer base, boost sales, and drive revenue growth. A sample purification system encompasses a suite of processes and technologies designed to eliminate impurities and contaminants from various sample types, including DNA, RNA, proteins, and other biomolecules. As an illustration, in February 2023, Biological Dynamics Inc., a prominent US-based biotechnology company, introduced ExoVerita-an exosome-isolation platform designed for early disease surveillance and diverse applications. The ExoVita Pancreas assay, part of this platform, identifies specific exosomal protein indicators and has demonstrated the ability to detect Stage 1 and Stage 2 pancreatic ductal adenocarcinoma (PDAC) using blood-based exosome samples enriched on the patented ExoVerita apparatus. The company is actively validating these findings through the ExoLuminate registry trial (NCT05625529), recruiting high-risk PDAC patients to assess the clinical value of the test.

In June 2023, Evox Therapeutics Ltd., a biotechnology company based in the UK, acquired the engEx-AAV technology platform from Codiak Biosciences for an undisclosed sum. The purpose of this acquisition is to utilize the engEx-AAV technology to improve exosome-mediated delivery systems, facilitating the advancement of innovative gene therapies and genome editors. This strategic decision aims to bolster Evox Therapeutics' capabilities in developing effective genetic medicines. Codiak Biosciences is a biopharmaceutical company located in the US that focuses on creating exosome-based therapeutics.

Major companies operating in the exosome diagnostic and therapeutic market are Thermo Fisher Scientific Inc., Miltenyi Biotec GmbH, Malvern Instruments Inc., System Biosciences LLC, NanoSomix Inc., Exosome Diagnostics Inc., Evox Therapeutics Ltd., ExCoBio Inc., Codiak BioSciences Inc., Capricor Therapeutics Inc., Aethlon Medical Inc., NX Pharmagen Inc., Aegle Therapeutic Corporation, Ciloa, Sistemic Inc., Theoria Science, Mantra Bio Inc., Lonza Group AG, Bio-Techne Corp.

North America was the largest region in the exosome diagnostic and therapeutic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the exosome diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The exosome diagnostic and therapeutic market consists of revenues earned by entities by providing services such as genomic sequencing, exome sequencing, resequencing, and targeted sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome diagnostic and therapeutic market also includes sales of exosome-based assays, exosome flow cytometry kits, and protein biomarker detection kits, which are used in providing exosome-based drug delivery services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Diagnostic And Therapeutic Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses exosome diagnostic and therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome diagnostic and therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exosome diagnostic and therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Instruments; Software; Reagents And Kits
  • 2) By Application: Diagnostics; Therapeutic
  • 3) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Other End Users
  • Subsegments:
  • 1) By Instruments: Exosome Isolation Systems; Characterization Instruments; Analysis Devices
  • 2) By Software: Data Analysis Software; Exosome Profiling Software
  • 3) By Reagents And KITS: Isolation KITS; Characterization Reagents; Assay KITS
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Miltenyi Biotec GmbH; Malvern Instruments Inc.; System Biosciences LLC; NanoSomix Inc.; Exosome Diagnostics Inc.; Evox Therapeutics Ltd.; ExCoBio Inc.; Codiak BioSciences Inc.; Capricor Therapeutics Inc.; Aethlon Medical Inc.; NX Pharmagen Inc.; Aegle Therapeutic Corporation; Ciloa; Sistemic Inc.; Theoria Science; Mantra Bio Inc.; Lonza Group AG; Bio-Techne Corp.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Exosome Diagnostic And Therapeutic Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Exosome Diagnostic And Therapeutic Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Exosome Diagnostic And Therapeutic Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Exosome Diagnostic And Therapeutic Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Use Of Exosomes For Targeted Drug Delivery
    • 4.2.2 Rising Adoption Of Liquid Biopsy Diagnostics
    • 4.2.3 Growing Demand For Regenerative Medicine Applications
    • 4.2.4 Expansion Of Advanced Exosome Isolation Technologies
    • 4.2.5 Enhanced Focus On Precision Therapeutic Development

5. Exosome Diagnostic And Therapeutic Market Analysis Of End Use Industries

  • 5.1 Academic And Research Institutes
  • 5.2 Pharmaceutical Companies
  • 5.3 Biotechnology Companies
  • 5.4 Hospitals And Clinics
  • 5.5 Contract Research Organizations

6. Exosome Diagnostic And Therapeutic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Exosome Diagnostic And Therapeutic Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Exosome Diagnostic And Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Exosome Diagnostic And Therapeutic Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Exosome Diagnostic And Therapeutic Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Exosome Diagnostic And Therapeutic Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Exosome Diagnostic And Therapeutic Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Exosome Diagnostic And Therapeutic Market Segmentation

  • 9.1. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Software, Reagents And Kits
  • 9.2. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostics, Therapeutic
  • 9.3. Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users
  • 9.4. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Exosome Isolation Systems, Characterization Instruments, Analysis Devices
  • 9.5. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis Software, Exosome Profiling Software
  • 9.6. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Reagents And KITS, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Isolation KITS, Characterization Reagents, Assay KITS

10. Exosome Diagnostic And Therapeutic Market Regional And Country Analysis

  • 10.1. Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Exosome Diagnostic And Therapeutic Market

  • 11.1. Asia-Pacific Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Exosome Diagnostic And Therapeutic Market

  • 12.1. China Exosome Diagnostic And Therapeutic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Exosome Diagnostic And Therapeutic Market

  • 13.1. India Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Exosome Diagnostic And Therapeutic Market

  • 14.1. Japan Exosome Diagnostic And Therapeutic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Exosome Diagnostic And Therapeutic Market

  • 15.1. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Exosome Diagnostic And Therapeutic Market

  • 16.1. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Exosome Diagnostic And Therapeutic Market

  • 17.1. South Korea Exosome Diagnostic And Therapeutic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Exosome Diagnostic And Therapeutic Market

  • 18.1. Taiwan Exosome Diagnostic And Therapeutic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Exosome Diagnostic And Therapeutic Market

  • 19.1. South East Asia Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Exosome Diagnostic And Therapeutic Market

  • 20.1. Western Europe Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Exosome Diagnostic And Therapeutic Market

  • 21.1. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Exosome Diagnostic And Therapeutic Market

  • 22.1. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Exosome Diagnostic And Therapeutic Market

  • 23.1. France Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Exosome Diagnostic And Therapeutic Market

  • 24.1. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Exosome Diagnostic And Therapeutic Market

  • 25.1. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Exosome Diagnostic And Therapeutic Market

  • 26.1. Eastern Europe Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Exosome Diagnostic And Therapeutic Market

  • 27.1. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Exosome Diagnostic And Therapeutic Market

  • 28.1. North America Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Exosome Diagnostic And Therapeutic Market

  • 29.1. USA Exosome Diagnostic And Therapeutic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Exosome Diagnostic And Therapeutic Market

  • 30.1. Canada Exosome Diagnostic And Therapeutic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Exosome Diagnostic And Therapeutic Market

  • 31.1. South America Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Exosome Diagnostic And Therapeutic Market

  • 32.1. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Exosome Diagnostic And Therapeutic Market

  • 33.1. Middle East Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Exosome Diagnostic And Therapeutic Market

  • 34.1. Africa Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Exosome Diagnostic And Therapeutic Market Regulatory and Investment Landscape

36. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Company Profiles

  • 36.1. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Exosome Diagnostic And Therapeutic Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Exosome Diagnostic And Therapeutic Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Miltenyi Biotec GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Malvern Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. System Biosciences LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. NanoSomix Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Exosome Diagnostic And Therapeutic Market Other Major And Innovative Companies

  • Exosome Diagnostics Inc., Evox Therapeutics Ltd., ExCoBio Inc., Codiak BioSciences Inc., Capricor Therapeutics Inc., Aethlon Medical Inc., NX Pharmagen Inc., Aegle Therapeutic Corporation, Ciloa, Sistemic Inc., Theoria Science, Mantra Bio Inc., Lonza Group AG, Bio-Techne Corp.

38. Global Exosome Diagnostic And Therapeutic Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Exosome Diagnostic And Therapeutic Market

40. Exosome Diagnostic And Therapeutic Market High Potential Countries, Segments and Strategies

  • 40.1 Exosome Diagnostic And Therapeutic Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Exosome Diagnostic And Therapeutic Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Exosome Diagnostic And Therapeutic Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer